Home > Research > Publications & Outputs > Therapeutic potential of flavonoids in spinal c...

Electronic data

  • Golcer

    Rights statement: ©2017 Walter de Gruyter GmbH, Berlin/Boston.

    Accepted author manuscript, 813 KB, PDF document

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License


Text available via DOI:

View graph of relations

Therapeutic potential of flavonoids in spinal cord injury

Research output: Contribution to Journal/MagazineJournal articlepeer-review

<mark>Journal publication date</mark>01/2017
<mark>Journal</mark>Reviews in the Neurosciences
Issue number1
Number of pages15
Pages (from-to)87-101
Publication StatusPublished
Early online date3/01/17
<mark>Original language</mark>English


Spinal cord injury (SCI) is a catastrophic event that can profoundly affect a patient's life, with far-reaching social and economic effects. A consequential sequence of SCI is the significant neurological or psychological deficit, which obviously contributes to the overall burden of this condition. To date, there is no effective treatment for SCI. Therefore, developing novel therapeutic strategies for SCI is highly prioritized. Flavonoids, one of the most numerous and ubiquitous groups of plant metabolites, are the active ingredients of traditional Chinese medicine such as Scutellaria baicalensis Georgi (Huang Qin) or Ginkgo biloba (Ying Xin). Accumulated research data show that flavonoids possess a range of key pharmacological properties such as anti-inflammatory, anti-oxidant, anti-tumor, anti-viral, anti-cardiovascular disease, immunomodulatory, and neuroprotective effects. Based on this, the flavonoids show therapeutic potential for SCI diseases. In this paper, we will review the pharmacological properties of different types of flavonoids for the treatment of SCI diseases, and potential underlying biochemical mechanisms of action will also be described.

Bibliographic note

©2017 Walter de Gruyter GmbH, Berlin/Boston.